✦ LIBER ✦

Autoimmune diabetes: NKG2D receptor: a therapeutic target?

✍ Scribed by Brazil, Melanie

Book ID: 109949573
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 177 KB
Volume: 3
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd1475

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NKG2D Blockade Prevents Autoimmune Diabe

NKG2D Blockade Prevents Autoimmune Diabetes in NOD Mice

✍ Kouetsu Ogasawara; Jessica A Hamerman; Lauren R Ehrlich; Helene Bour-Jordan; Per 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 845 KB

The role of the activating receptor NKG2

The role of the activating receptor NKG2D in autoimmunity

✍ Tom L. Van Belle; Matthias G. von Herrath 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Inhibitory NKG2A and activating NKG2D an

Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis

✍ K. S. Park; J. H. Park; Y. W. Song 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Spotting a killer's target in autoimmune

Spotting a killer's target in autoimmune diabetes

✍ Benoist, Christophe; Mathis, Diane 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Adenosine A2B receptors as therapeutic t

Adenosine A2B receptors as therapeutic targets

✍ Igor Feoktistov; Jack N. Wells; Italo Biaggioni 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Recent evidence indicates that A 2B receptors mediate cellular functions with potential clinical relevance. Both A 2A and A 2B receptors mediate vasodilation, and the receptor type involved depends on the vascular bed and species studied. In some experimental models, A 2B -induced vasodilation is me

EGF receptor as a therapeutic target

✍ Levitzki, Alexander 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 214 KB